Search Results - "CESSON, Valérie"
-
1
Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy
Published in Scientific reports (05-08-2024)“…Prostate-Specific Antigen (PSA) based screening of prostate cancer (PCa) needs refinement. The aim of this study was the identification of urinary biomarkers…”
Get full text
Journal Article -
2
Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses
Published in PloS one (08-06-2017)“…Antibody based immune-checkpoint blockade therapy is a major breakthrough in oncology, leading to clinical benefit for cancer patients. Among the growing…”
Get full text
Journal Article -
3
Targeting Endothelial Connexin37 Reduces Angiogenesis and Decreases Tumor Growth
Published in International journal of molecular sciences (08-03-2022)“…Connexin37 (Cx37) and Cx40 form intercellular channels between endothelial cells (EC), which contribute to the regulation of the functions of vessels. We…”
Get full text
Journal Article -
4
Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer
Published in Cancers (23-02-2022)“…PCa screening is based on the measurements of the serum prostate specific antigen (PSA) to select men with higher risks for tumors and, thus, eligible for…”
Get full text
Journal Article -
5
Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle-Invasive Bladder Cancer Patients
Published in Clinical cancer research (01-02-2017)“…Treatments with cancer vaccines may be delivered as combination therapies for better efficacy. Addition of intravesical immunostimulation with bacteria…”
Get full text
Journal Article -
6
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential
Published in Journal for immunotherapy of cancer (14-12-2023)“…BackgroundStandard of care treatment of non-muscle invasive bladder cancer (NMIBC) with intravesical Bacillus Calmette Guérin (BCG) is associated with side…”
Get full text
Journal Article -
7
Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
Published in European urology open science (Online) (01-12-2021)“…Aberrant glycosylation actively contributes to tumor progression and is a key hallmark of cancer. Most of the glycan moieties expressed on the surface of…”
Get full text
Journal Article -
8
Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer
Published in Oncoimmunology (02-01-2017)“…Intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy can reduce recurrence/progression of non-muscle-invasive bladder cancer (NMIBC), although significant…”
Get full text
Journal Article -
9
Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer
Published in Cancers (08-06-2023)“…Benign prostate hyperplasia (BPH) is a frequent condition in aging men, which affects life quality, causing principally lower urinary tract symptoms…”
Get full text
Journal Article -
10
Intravesical Ty21a Treatment of Non–muscle-invasive Bladder Cancer Shows a Good Safety Profile
Published in European urology open science (Online) (01-11-2022)“…Standard-of-care immunotherapy for non–muscle-invasive bladder cancer (NMIBC) with intravesical Bacillus Calmettte-Guérin (BCG) is associated with adverse…”
Get full text
Journal Article -
11
Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments
Published in Journal for immunotherapy of cancer (01-08-2022)“…Background Bladder cancer is an important public health concern due to its prevalence, high risk of recurrence and associated cost of management. Although BCG…”
Get full text
Journal Article -
12
Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients
Published in European urology focus (01-05-2022)“…Among the growing family of inhibitory receptors regulating immunity, sialic acid–binding immunoglobulin domain–containing lectins (Siglecs) have recently…”
Get full text
Journal Article -
13
Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in mice
Published in The Journal of clinical investigation (01-03-2008)“…Invariant NKT (iNKT) cells are potent activators of DCs, NK cells, and T cells, and their antitumor activity has been well demonstrated. A single injection of…”
Get full text
Journal Article -
14
Intramuscular Immunization Induces Antigen-specific Antibodies in Urine
Published in European urology focus (15-03-2020)“…Towards the development of vaccines against urinary tract infections (UTI), we determined the ability of intramuscular (i.m.) immunization to result in…”
Get full text
Journal Article -
15
MAGE-A3 and MAGE-A4 specific CD4+ T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes
Published in Cancer Immunology, Immunotherapy (01-01-2011)“…Frequent expression of cancer testis antigens (CTA) has been consistently observed in head and neck squamous cell carcinomas (HNSCC). For instance, in 52 HNSCC…”
Get full text
Journal Article -
16
MHC Class I–Related Chain A Conjugated to Antitumor Antibodies Can Sensitize Tumor Cells to Specific Lysis by Natural Killer Cells
Published in Clinical cancer research (15-10-2005)“…Purpose: As a first step for the development of a new cancer immunotherapy strategy, we evaluated whether antibody-mediated coating by MHC class I–related…”
Get full text
Journal Article -
17
ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence
Published in The Journal of clinical investigation (01-08-2017)“…Non-muscle-invasive bladder cancer (NMIBC) is a highly recurrent tumor despite intravesical immunotherapy instillation with the bacillus Calmette-Guérin (BCG)…”
Get full text
Journal Article -
18
Double Positive CD4 + CD8 + T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization
Published in Frontiers in immunology (29-03-2019)“…The immune system plays a central role in cancer development, showing both anti-tumor and pro-tumor activities depending on the immune cell subsets and the…”
Get full text
Journal Article -
19
Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates
Published in Clinical cancer research (15-12-2006)“…To redirect an ongoing antiviral T-cell response against tumor cells in vivo, we evaluated conjugates consisting of antitumor antibody fragments coupled to…”
Get full text
Journal Article -
20
Disulfide-Linked Peptides for Blocking BTLA/HVEM Binding
Published in International journal of molecular sciences (18-01-2020)“…Immune checkpoints are crucial in the maintenance of antitumor immune responses. The activation or blockade of immune checkpoints is dependent on the…”
Get full text
Journal Article